Skip to main content

Table 1 Profiles of the patients studied

From: Association of cerebrospinal fluid anti-ribosomal P protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus

Diagnosis

Number of patients

Gender (male/female)

Age in years (mean ± SD)

SLE

103

  

Diffuse NP-SLE

52

4/48

37.8 ± 14.2

   Acute confusional state

20

  

   Anxiety disorder

3

  

   Cognitive dysfunction

10a

  

   Mood disorder

12b

  

   Psychosis

7

  

Focal NP-SLE

19

2/17

39.0 ± 14.8

   Cerebrovascular disease

6

  

   Headache

2

  

   Movement disorder

1

  

   Seizure disorder

6

  

   Polyneuropathy

4

  

Non-CNS SLE

32

3/29

42.7 ± 13.9

Non-SLE control

24

22/2

48.0 ± 13.7

  1. aOne patient also presented mood disorder. bOne patient also presented cognitive dysfunction. Non-CNS SLE, systemic lupus erythematosus without neuropsychiatric manifestations; NP-SLE, neuropsychiatric systemic lupus erythematosus; SD, standard deviation; SLE, systemic lupus erythematosus.